Oncolytics Biotech Inc - ESG Rating & Company Profile powered by AI
The webpage of Oncolytics Biotech Inc is prepared by All Street Sevva using advanced Cognitive Robots. Check the end of this webpage for potential risks for Oncolytics Biotech Inc based on sector, location and marketcap. This page is a zero-cost Environmental, Social and Governance report for Oncolytics Biotech Inc.
Oncolytics Biotech Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.4; made up of an environmental score of 5.3, social score of 8.0 and governance score of 6.0.
6.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 389 | WuXi Biologics (Cayman) Inc | 6.6 | High |
| 401 | Oxford Cannabinoid Technologies Holdings PLC | 6.5 | High |
| 402 | Oncolytics Biotech Inc | 6.4 | High |
| 402 | Capricor Therapeutics Inc | 6.4 | High |
| 402 | Alembic Pharmaceuticals Ltd | 6.4 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Oncolytics Biotech Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Oncolytics Biotech Inc report the average age of the workforce?
Sign up for free to unlockDoes Oncolytics Biotech Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Oncolytics Biotech Inc offer flexible work?
Sign up for free to unlockDoes Oncolytics Biotech Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Oncolytics Biotech Inc conduct supply chain audits?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Oncolytics Biotech Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose water use targets?
Sign up for free to unlockDoes Oncolytics Biotech Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Oncolytics Biotech Inc have a product recall in the last two years?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Oncolytics Biotech Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Oncolytics Biotech Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose parental leave metrics?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Oncolytics Biotech Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Oncolytics Biotech Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Oncolytics Biotech Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose its waste policy?
Sign up for free to unlockDoes Oncolytics Biotech Inc report according to TCFD requirements?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose energy use targets?
Sign up for free to unlockDoes Oncolytics Biotech Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Oncolytics Biotech Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Oncolytics Biotech Inc
These potential risks are based on the size, segment and geographies of the company.
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada.